Efficacy and safety of 4 weeks' treatment with combined fluticasone furoate/vilanterol in a single inhaler given once daily in COPD: a placebo-controlled randomised trial

BACKGROUND: Fluticasone furoate/vilanterol (FF/VI) is a novel once-daily (OD) inhaled corticosteroid/long-acting β(2) agonist combination in development for chronic obstructive pulmonary disease (COPD) and asthma. TRIAL DESIGN: A multicentre, randomised, double-blind, parallel-group, placebo-control...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Lötvall, J, Bakke, P S, Bjermer, L, Steinshamn, S, Scott-Wilson, C, Crim, C, Sanford, L, Haumann, B
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2012
Assuntos:
Respiratory Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3263438/
https://ncbi.nlm.nih.gov/pubmed/22267687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2011-000370
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados